DOJ reports California physician sentenced in Medicare Botox billing case
View the illustration with DOJ reports California physician sentenced in Medicare Botox billing case →
Scope: DOJ is the source for the sentencing account. The judgment, appeal status and actual collections or net recovery have not been independently established.
Summary
DOJ reports that a California physician received a 15-year sentence after convictions in a Medicare Botox billing scheme. The court ordered restitution and forfeiture, with restitution collection and net recovery not established in the announcement.
What changed
DOJ announced October 30 that a federal court sentenced California physician Violetta Mailyan to 15 years in prison on October 29. DOJ reports that, following a six-day jury trial ending in May 2026, she was convicted of nine wire-fraud counts and three counts of obstruction of a criminal investigation of a health care offense. DOJ says the case involved more than $45 million billed to Medicare for Botox services that were medically unnecessary or never provided. According to the release’s account of trial evidence, thousands of billed injections were never given, were cosmetic, or involved patients whose primary-care physicians had not referred them for chronic-migraine treatment; claims representing more than $19 million purportedly concerned days when the clinic was closed. Those are billed amounts, not a finding that the same amount was paid or recovered.
DOJ reports that the court ordered $32,904,049.41 in restitution to Medicare and immediate forfeiture of more than $16,029,742 in seized property, including real and personal property, securities and bank funds. Those are distinct court-ordered amounts; the announcement does not establish the amount of restitution collected or net recovery after any allocation. DOJ also describes evidence of falsified medical records and forged beneficiary signatures submitted to investigators. This account is based on the agency’s announcement. The judgment, appeal status, trial record and actual collections or net recovery have not been independently established.
Why it matters
For providers administering high-cost injectable drugs, the reported conduct illustrates the value of reconciling documentation and billing against actual patient encounters, clinical indications, drug administration and practitioner availability.
Suggested action
Compliance and revenue-cycle owners can test a risk-based sample for services billed during office closures or provider absences and investigate discrepancies, while preserving records and escalating suspected falsification through established procedures. The case does not establish that an unmatched referral alone proves fraud or that a particular organization has violated a rule.
Sources
Hive ransomware sentencing
View the illustration with Hive ransomware sentencing →
Scope: This account is attributed to DOJ. The announcement is not a court judgment, and broader source coverage remains incomplete.
On October 27, a federal court sentenced Artem Stryzhak to 70 months in prison for his role in Hive ransomware activity, DOJ reported. DOJ attributed roughly 1,500 victims to the wider conspiracy and seven victims to Stryzhak and co-conspirators. DOJ described a hospital disruption in its account of the wider group; it did not identify that hospital as one of the seven.
The reported disruptions illustrate the importance of healthcare continuity and recovery planning. They do not establish that every victim suffered the same harm or that all ransom proceeds were recovered.
DOJ reports that Stryzhak pleaded guilty in December 2025 and describes an FBI-provided decryption key supplied to one victim without a ransom payment. Those facts do not establish the same outcome for every victim.
Suggested action: Healthcare organizations can test their own downtime and recovery plans, including how teams communicate and prioritize patient services when systems are unavailable. These are suggested risk-management steps, not new duties established by the sentence.
DOJ sentencing announcement
California hospice enrollment decision
View the illustration with California hospice enrollment decision →
Scope: This is an administrative decision concerning an earlier revocation, not a newly imposed 2026 revocation. Current appeal and preclusion status remain open.
In an October 27, 2026 decision, an HHS administrative law judge affirmed CMS’s authority to revoke Glencare’s Medicare enrollment and place it on the preclusion list, based on the billing findings described in the decision. The contractor’s original notice was issued in August 2024, and the revocation took effect in September 2024. The judge said the length of the ten-year reenrollment bar was outside the judge’s review authority.
Why it matters: The decision concerns this hospice’s enrollment appeal; it does not establish a general hospice error rate or a criminal conviction.
Suggested action: Providers facing an enrollment action can review the applicable response and appeal process promptly, identify who holds relevant billing and clinical records, and preserve and submit supporting evidence at the appropriate stage.
HHS ALJ decision CR7006
Kentucky dialysis communication agreement
View the illustration with Kentucky dialysis communication agreement →
Scope: This is a case-specific agreement. Many of its communication measures apply to defined Kentucky facilities; this account does not establish completed payments or a nationwide mandate.
On October 27, DOJ announced an ADA settlement following a complaint concerning communication with a deaf patient at a Lexington, Kentucky dialysis facility. DOJ said its investigation substantiated the complaint and that DaVita cooperated. The agreement says DaVita denies the allegations and is not admitting liability. DOJ describes updates to communication policies and practices, staff training and complaint reporting. The agreement describes measures for defined Kentucky facilities and provides for compensation and a civil penalty, subject to its conditions; it does not establish that those amounts have been paid.
The agreement highlights the importance of assessing effective communication and documenting appropriate services for patients with disabilities. Organizations should assess their own obligations and circumstances rather than assume the case-specific agreement applies to every facility.
Suggested action: Organizations can review how they assess communication needs, make appropriate services available and document follow-through on concerns. They should assess their own applicable obligations rather than treat this agreement as a mandate for every provider.
DOJ announcement | Agreement
Virginia behavioral-health charges
View the illustration with Virginia behavioral-health charges →
Scope: The charges are allegations, and the defendant is presumed innocent unless proven guilty. The amount describes alleged claims, not an established loss, payment or recovery.
On October 28, DOJ announced the arrest of a Virginia mental-health provider executive charged in connection with Medicaid crisis-services billing. DOJ alleges more than $49 million in false claims were submitted from January 2022 through April 2026, and describes alleged discrepancies between documented and actual staffing, falsified signatures and inducements. The indictment was returned October 20; the charges are allegations, and the defendant is presumed innocent unless proven guilty.
Why it matters: The announcement describes alleged conduct in one case; it does not establish that other behavioral-health providers engaged in the same conduct.
Suggested action: Compliance teams can compare actual clinician participation and credentials with service records and submitted claims, and investigate material discrepancies through established processes. This is a suggested internal review, not a new requirement imposed on other providers by the case.
DOJ announcement